U.S. Capital Markets Stock News

Wondering whether MercadoLibre at around US$1,850 per share still offers value, or if the best days of the stock are behind it? This article walks through the numbers so you can judge for yourself. The share price has moved by 0.8% over the last 7 days and 7.6% over the last 30 days, while the year to date return is a 6.3% decline and the 1 year return is an 18.9% decline, set against a 3 year return of 48.8% and a 5 year return of 24.9%. Recent headlines around MercadoLibre have focused on...

Melco Resorts & Entertainment (NasdaqGS:MLCO) heads into its Q1 2026 update with recent quarterly numbers that put revenue at about US$1.3b in Q4 2025 and basic EPS at US$0.16. This caps off a year where trailing twelve month EPS reached US$0.46 on revenue of roughly US$5.2b. Over the past few quarters, the company has seen revenue range between US$1.2b and US$1.3b per quarter, while basic EPS moved from US$0.08 in Q1 2025 to US$0.19 in Q3 before landing at US$0.16 in Q4. This result comes...

Ares Management (NYSE:ARES) has appointed Peter Ogilvie as Chief Operating Officer and Head of Strategy. Ogilvie is tasked with driving global growth initiatives across the firm’s platform. The move reflects a leadership shift that could influence how Ares pursues expansion and integration of future acquisitions. Ares Management, trading at $119.0, has mixed recent performance, with a 3.3% return over the past week and 12.5% over the past month, set against a 28.5% decline year to date and...

Q2 Holdings (NYSE:QTWO) has introduced new AI driven fraud prevention tools focused on continuous account takeover protection. The company has also rolled out Q2 Treasury Fulfillment, a solution aimed at streamlining and automating treasury onboarding for commercial clients. Both features expand Q2's digital banking platform beyond its recent earnings updates, targeting fraud risk and onboarding friction for financial institutions. Q2 Holdings enters this product update cycle with its...

Halozyme Therapeutics (NasdaqGS:HALO) has appointed Darren Snellgrove as Chief Financial Officer. Snellgrove is described as a seasoned financial executive with extensive biopharmaceutical experience. The CFO appointment represents a key leadership change that may influence future capital allocation and corporate priorities. For investors following biopharma platforms, Halozyme Therapeutics focuses on drug delivery technologies and partnerships with larger pharmaceutical companies. A CFO...

Royal Caribbean Cruises Ltd. reported past first‑quarter 2026 results with revenue of US$4,452 million and net income of US$941 million, lifting diluted EPS from continuing operations to US$3.48 from US$2.70 a year earlier. Alongside the earnings beat, the company confirmed orders for sixth and seventh Icon Class ships and updated full‑year adjusted EPS guidance to US$17.10–US$17.50, tying near‑term performance to a multi‑year fleet expansion and product investment plan. With first‑quarter...

Caterpillar has caught the eye of many investors lately, and if you are wondering whether the current share price offers good value, the numbers provide a useful starting point. At a last close of US$889.67, the stock has delivered returns of 7.1% over 7 days, 21.8% over 30 days, 48.7% year to date, 177.8% over 1 year, 332.8% over 3 years and 303.7% over 5 years. That naturally raises questions about how much of the story is already reflected in the price. Recent headlines around Caterpillar...

If you are trying to work out whether State Street's current share price reflects its real worth, the recent trading history gives you a lot to think about. The stock last closed at US$152.00, with returns of 0.8% over 7 days, 18.5% over 30 days, 17.8% year to date, 72.6% over 1 year, 144.9% over 3 years and 104.4% over 5 years. These moves have sharpened interest in how the market is pricing the bank's role in global custody and asset servicing, as well as its exposure to broader capital...

In late April 2026, Merck reported stronger-than-expected first-quarter results, raised its full-year revenue and earnings guidance, and secured FDA approval for IDVYNSO, a complete two-drug HIV-1 regimen for virologically suppressed adults. Together with advancing oncology programs such as KEYTRUDA-based regimens and WELIREG in renal cell carcinoma, these developments reinforce Merck’s efforts to broaden growth drivers ahead of expected pressure on legacy products. We’ll now examine how...

Xenon Pharmaceuticals (XENE) is back in focus after presenting Phase 3 X-TOLE2 data for azetukalner in adults with focal onset seizures, supported by long term X-TOLE extension and real world no titration feedback. See our latest analysis for Xenon Pharmaceuticals. The latest clinical update has arrived after a strong few quarters for the stock, with a 36.87% 90 day share price return and a 46.63% 1 year total shareholder return that suggest momentum has been building around Xenon’s lead...

Tempus AI (TEM) is back in focus after TIME named it one of the 10 Most Influential Health and Life Science Companies of 2026, alongside fresh oncology partnerships and upcoming earnings and Investor Day milestones. See our latest analysis for Tempus AI. Tempus AI’s recent recognition and oncology tie ups come as the share price trades at US$55.0, with a 16.06% 30 day share price return but an 11.80% year to date share price decline and a 3.61% 1 year total shareholder return decline. This...

Arteris (AIP) shares were in focus after the company announced a new collaboration with MIPS, a GlobalFoundries company, to support physical AI computing platforms across automotive, robotics, and embedded computing markets. See our latest analysis for Arteris. The collaboration news arrives after a strong run in Arteris shares, with a 30 day share price return of 64.96% and a year to date share price return of 85.82%. The 1 year total shareholder return is 330.80% and the 3 year total...

Polaris Inc. reported past first-quarter 2026 results with sales rising to US$1,658.7 million from US$1,535.8 million, while narrowing its net loss to US$47.4 million from US$66.8 million and reducing loss per share from US$1.17 to US$0.83. The quarter also showed an 8% revenue increase, gross margin expansion despite tariff pressures, and double-digit growth in key utility and commercial powersports lines, highlighting underlying operational improvements. We’ll now examine how Polaris’s...

Rocket Companies, which owns Redfin, is heading into its 7 May 2026 earnings release with analysts expecting higher quarterly revenue and a year-over-year earnings increase, as recent estimate revisions have turned more positive. Fresh housing data from Redfin showing rising pending home sales, stronger mortgage-application activity and slightly improved affordability highlights how macro housing trends are feeding directly into Rocket’s operating backdrop. Next, we’ll examine how improving...

GoDaddy (GDDY) opened 2026 with Q1 revenue of US$1.27 billion and basic EPS of US$1.61, setting the tone for how its hosting and domains business is translating scale into earnings. The company reported quarterly revenue of US$1.19 billion in Q1 2025 and US$1.27 billion in Q1 2026, with basic EPS moving from US$1.55 to US$1.61 over the same period, while trailing twelve month EPS reached US$6.39 on US$5.02 billion of revenue. With net profit margin at 17.3% over the last year, these results...

Shopify (SHOP) is back in focus after recent 2025 results framed it as a profitable compounder, with management outlining broad based growth, AI powered commerce initiatives, and a confident revenue outlook. See our latest analysis for Shopify. The stock has been volatile around recent AI commerce updates and investor commentary, with a 5.4% 1 day share price return and a year to date share price decline of 18.8%, set against a 1 year total shareholder return of 28.6% and a 3 year total...

Pioneer Bancorp (PBFS) opened Q1 2026 with total revenue of US$23.8 million and basic EPS of US$0.22, setting the tone for how its earnings story is evolving after a year in which trailing 12 month net income reached US$19.8 million. Over recent quarters, the bank has reported total revenue ranging from US$21.2 million in Q4 2024 to US$24.5 million in Q4 2025. Over the same span, quarterly basic EPS moved between US$0.13 and US$0.26, giving investors a clearer view of how profits have tracked...

In late April 2026, Kirby Corporation reported Q1 2026 results showing revenue of US$844.1 million and net income of US$81.2 million, with diluted EPS from continuing operations rising to US$1.50 from US$1.33 a year earlier. Beyond the headline growth, Kirby raised its full-year EPS guidance, expanded its barge fleet, and repurchased US$52.7 million of shares, signaling management’s confidence despite identified headwinds from diesel costs and engine supply delays. Next, we’ll explore how...

Merlin (NasdaqGM:MRLN) has entered an exclusive partnership with UAE based Remah International Group to introduce its AI powered autonomous flight systems in the United Arab Emirates. The agreement gives Merlin a new route into Middle East defense and aviation markets at a time of shifting regional security priorities. The move marks one of Merlin's first announced commercial steps to bring its technology to customers outside the U.S. For investors watching Merlin at a current share price...

This article reviews Ellington Financial's recent numbers so you can consider for yourself whether the current price represents good value. The stock last closed at US$13.24, with returns of 0.8% over 7 days, 11.3% over 30 days, a 3.2% decline year to date, and 14.6% over the past year, which provides a mixed picture of sentiment and risk. Recent company updates and sector headlines around mortgage REITs have kept attention on funding costs and asset quality. This context helps frame how...

In late April 2026, Ormat Technologies announced that analysts expected the company to report higher year-over-year earnings and revenue for the March 2026 quarter, ahead of its scheduled earnings release on May 6. This brighter analyst outlook, reflected in estimates above the broader consensus, underscores growing confidence in Ormat’s near-term earnings power and project pipeline execution. With analyst expectations improving ahead of the May 6 earnings report, we’ll now examine how this...

Why Sempra stock is on investors’ radar Sempra (SRE) shares have delivered a 29.3% total return over the past year, prompting investors to reassess how the regulated utility’s mix of California, Texas, and infrastructure assets lines up with their income and stability goals. See our latest analysis for Sempra. Recent trading has been mixed, with a 1.6% 7 day share price return and an 8.8% 90 day share price return. The 1 year total shareholder return of 29.3% highlights how income and...

If you are wondering whether Southern is priced attractively right now, the starting point is to look at how its current share price lines up with different measures of underlying value. The stock last closed at US$96.71, with returns of 3.4% over 7 days, 10.9% year to date, and 9.7% over the past year, so recent moves may have shifted how you think about its risk and return trade off. Recent coverage around Southern has focused on its role within the US utilities sector and how investors...

Hotel101 Global Holdings (NasdaqCM:HBNB) has just posted its FY 2025 first half numbers, with revenue of about US$16.9 million and a basic EPS loss of US$0.07. This was set against an extremely large reported revenue growth figure of 2,362,191.3% over the last 12 months while the business remained loss making. Over recent periods, the company has seen revenue move from roughly US$0.0 million in the first half of 2024 to US$16.9 million in the first half of 2025, while trailing twelve month...